{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:52:43Z","timestamp":1794243163382,"version":"4.9.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Attributed to the immunosuppression caused by malignancy itself and its treatments, cancer patients are vulnerable to developing nosocomial infections. This study aimed to develop a nomogram to predict the in-hospital death risk of these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study was conducted at a medical center in Northwestern China. The univariate and multivariate logistic regression analyses were adopted to identify predictive factors for in-hospital mortality of nosocomial infections in cancer patients. A nomogram was developed to predict the in-hospital mortality of each patient, with receiver operating characteristic curves and calibration curves being generated to assess its predictive ability. Furthermore, decision curve analysis (DCA) was also performed to estimate the clinical utility of the nomogram.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1,008 nosocomial infection episodes were recognized from 14,695 cancer patients. Extended-spectrum \u03b2-lactamase (ESBL)-producing <jats:italic>Escherichia coli<\/jats:italic> (15.5%) was the most predominant causative pathogen. Besides, multidrug-resistant strains were discovered in 25.5% of cases. The multivariate analysis indicated that Eastern Cooperative Oncology Group Performance Status 3\u20134, mechanical ventilation, septic shock, hypoproteinemia, and length of antimicrobial treatment\u2009&lt;\u20097\u00a0days were correlated with higher in-hospital mortality. Patients who received curative surgery were correlated with favorable survival outcomes. Ultimately, a nomogram was constructed to predict the in-hospital mortality of nosocomial infections in cancer patients. The area under the curve values of the nomogram were 0.811 and 0.795 in the training and validation cohorts. The calibration curve showed high consistency between the actual and predicted in-hospital mortality. DCA indicated that the nomogram was of good clinical utility and more credible net clinical benefits in predicting in-hospital mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Nosocomial infections stay conjoint in cancer patients, with gram-negative bacteria being the most frequent causative pathogens. We developed and verified a nomogram that could effectively predict the in-hospital death risk of nosocomial infections among these patients. Precise management of high-risk patients, early recognition of septic shock, rapid and adequate antimicrobial treatment, and dynamic monitoring of serum albumin levels may improve the prognosis of these individuals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01073-3","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T13:03:44Z","timestamp":1644239024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Establishment and validation of a nomogram to predict the in-hospital death risk of nosocomial infections in cancer patients"],"prefix":"10.1186","volume":"11","author":[{"given":"Aimin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-2363","authenticated-orcid":false,"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"issue":"3","key":"1073_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1073_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/21505594.2016.1141161","volume":"7","author":"C Gudiol","year":"2016","unstructured":"Gudiol C, Aguado JM, Carratala J. Bloodstream infections in patients with solid tumors. Virulence. 2016;7(3):298\u2013308.","journal-title":"Virulence"},{"key":"1073_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-319-04220-6_2","volume-title":"Infectious complications in cancer patients","author":"TR Zembower","year":"2014","unstructured":"Zembower TR. Epidemiology of infections in cancer patients. In: Stosor V, Zembower TR, editors. Infectious complications in cancer patients. Cham: Springer International Publishing; 2014. p. 43\u201389."},{"issue":"6","key":"1073_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jinf.2016.04.003","volume":"72","author":"JS Brand","year":"2016","unstructured":"Brand JS, Colzani E, Johansson ALV, Giesecke J, Clements M, Bergh J, et al. Infection-related hospitalizations in breast cancer patients: risk and impact on prognosis. J Infect. 2016;72(6):650\u20138.","journal-title":"J Infect"},{"key":"1073_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1479-5876-7-14","volume":"7","author":"HM Ashour","year":"2009","unstructured":"Ashour HM, El-Sharif A. Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients. J Transl Med. 2009;7:14.","journal-title":"J Transl Med"},{"key":"1073_CR6","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2147\/IDR.S183283","volume":"11","author":"A Fentie","year":"2018","unstructured":"Fentie A, Wondimeneh Y, Balcha A, Amsalu A, Adankie BT. Bacterial profile, antibiotic resistance pattern and associated factors among cancer patients at University of Gondar Hospital. Northwest Ethiopia Infect Drug Resist. 2018;11:2169\u201378.","journal-title":"Northwest Ethiopia Infect Drug Resist"},{"issue":"1","key":"1073_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/jac\/49.1.69","volume":"49","author":"SS Jean","year":"2002","unstructured":"Jean SS, Teng LJ, Hsueh PR, Ho SW, Luh KT. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital. J Antimicrob Chemother. 2002;49(1):69\u201376.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1073_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0195-6701(98)90237-7","volume":"39","author":"MJ Crowe","year":"1998","unstructured":"Crowe MJ, Cooke EM. Review of case definitions for nosocomial infection\u2014towards a consensus. J Hosp Infect. 1998;39(1):3\u201311.","journal-title":"J Hosp Infect"},{"key":"1073_CR9","doi-asserted-by":"crossref","unstructured":"de la Varga-Mart\u00ednez O, G\u00f3mez-S\u00e1nchez E, Mu\u00f1oz MF, Lorenzo M, G\u00f3mez-Pesquera E, Poves-\u00c1lvarez R, et al. Impact of nosocomial infections on patient mortality following cardiac surgery. J Clin Anesthesia. 2021;69:110104.","DOI":"10.1016\/j.jclinane.2020.110104"},{"issue":"10","key":"1073_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791\u20137.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1073_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijantimicag.2016.11.009","volume":"49","author":"CY Chen","year":"2017","unstructured":"Chen CY, Tien FM, Sheng WH, Huang SY, Yao M, Tang JL, et al. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008\u20132013. Int J Antimicrob Agents. 2017;49(3):272\u201381.","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"1073_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):775\u201387.","journal-title":"JAMA"},{"issue":"4","key":"1073_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/cid\/ciq147","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427\u201331.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1073_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1\u201345.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1073_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12866-021-02133-1","volume":"21","author":"HS Elbadawi","year":"2021","unstructured":"Elbadawi HS, Elhag KM, Mahgoub E, Altayb HN, Ntoumi F, Elton L, et al. Detection and characterization of carbapenem resistant Gram-negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan. BMC Microbiol. 2021;21(1):136.","journal-title":"BMC Microbiol"},{"issue":"1","key":"1073_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1186\/s12879-019-4448-7","volume":"19","author":"G Dimomicronpoulos","year":"2019","unstructured":"Dimomicronpoulos G, Rovina N, Patrani M, Antoniadou E, Konstantonis D, Vryza K, et al. Past history of stage I\/II solid tumor malignancy impacts considerably on sepsis mortality: a propensity score matching analysis from the hellenic sepsis study group. BMC Infect Dis. 2019;19(1):831.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1073_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1470-2045(09)70069-5","volume":"10","author":"M Kamboj","year":"2009","unstructured":"Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10(6):589\u201397.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1073_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.apjtb.2015.09.015","volume":"5","author":"AM Nurain","year":"2015","unstructured":"Nurain AM, Bilal NE, Ibrahim ME. The frequency and antimicrobial resistance patterns of nosocomial pathogens recovered from cancer patients and hospital environments. Asian Pac J Trop Biomed. 2015;5(12):1055\u20139.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"2","key":"1073_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5005\/jp-journals-10071-23119","volume":"23","author":"VK Garg","year":"2019","unstructured":"Garg VK, Mishra S, Gupta N, Garg R, Sachidanand B, Vinod K, et al. Microbial and antibiotic susceptibility profile among isolates of clinical samples of cancer patients admitted in the intensive care unit at regional tertiary care cancer center: a retrospective observational study. Indian J Crit Care Med. 2019;23(2):67\u201372.","journal-title":"Indian J Crit Care Med"},{"issue":"2","key":"1073_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jgo.2018.06.011","volume":"10","author":"M Antonio","year":"2019","unstructured":"Antonio M, Gudiol C, Royo-Cebrecos C, Grillo S, Ardanuy C, Carratal\u00e0 J. Current etiology, clinical features and outcomes of bacteremia in older patients with solid tumors. J Geriatric Oncol. 2019;10(2):246\u201351.","journal-title":"J Geriatric Oncol"},{"issue":"5","key":"1073_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jmii.2011.01.035","volume":"44","author":"CC Huang","year":"2011","unstructured":"Huang CC, Wu CJ, Wang LR, Lee HC, Chang CM, Lee NY, et al. Antimicrobial susceptibility of bacteremic isolates from cancer patients with or without neutropenia at a medical center in southern Taiwan. J Microbiol Immunol Infect. 2011;44(5):376\u201381.","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"1073_CR22","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/jac\/dkt002","volume":"68","author":"S Schelenz","year":"2013","unstructured":"Schelenz S, Nwaka D, Hunter PR. Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. J Antimicrob Chemother. 2013;68(6):1431\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1073_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4274\/tjh.2015.0216","volume":"33","author":"N Calik Basaran","year":"2016","unstructured":"Calik Basaran N, Karaagaoglu E, Hascelik G, Durusu Tanriover M, Akova M. Prospective evaluation of infection episodes in cancer patients in a tertiary care academic center: microbiological features and risk factors for mortality. Turk J Haematol. 2016;33(4):311\u20139.","journal-title":"Turk J Haematol"},{"issue":"9","key":"1073_CR24","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36(9):1103\u201310.","journal-title":"Clin Infect Dis"},{"key":"1073_CR25","doi-asserted-by":"crossref","unstructured":"Perdikouri EIA, Arvaniti K, Lathyris D, Apostolidou Kiouti F, Siskou E, Haidich AB, et al. Infections due to multidrug-resistant bacteria in oncological patients: insights from a five-year epidemiological and clinical analysis. Microorganisms. 2019;7(9).","DOI":"10.3390\/microorganisms7090277"},{"issue":"3","key":"1073_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/jac\/dkq494","volume":"66","author":"C Gudiol","year":"2011","unstructured":"Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sanchez-Ortega I, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66(3):657\u201363.","journal-title":"J Antimicrob Chemother"},{"key":"1073_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/IDR.S192072","volume":"12","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Gao HY, Li D, Li Z, Qi SS, Zheng S, et al. Clinical outcome of Escherichia coli bloodstream infection in cancer patients with\/without biofilm formation: a single-center retrospective study. Infect Drug Resist. 2019;12:359\u201371.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"1073_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/MD.0000000000000026","volume":"93","author":"M Marin","year":"2014","unstructured":"Marin M, Gudiol C, Garcia-Vidal C, Ardanuy C, Carratala J. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore). 2014;93(3):143\u20139.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1073_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/sur.2018.246","volume":"20","author":"RH Tu","year":"2019","unstructured":"Tu RH, Lin JX, Desiderio J, Li P, Xie JW, Wang JB, et al. Does intra-abdominal infection after curative gastrectomy affect patients\u2019 long-term prognosis? A multi-center study based on a large sample size. Surg Infect (Larchmt). 2019;20(4):271\u20137.","journal-title":"Surg Infect (Larchmt)"},{"issue":"5","key":"1073_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijantimicag.2013.07.018","volume":"42","author":"YE Ha","year":"2013","unstructured":"Ha YE, Kang CI, Cha MK, Park SY, Wi YM, Chung DR, et al. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in patients with cancer. Int J Antimicrob Agents. 2013;42(5):403\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"1073_CR31","first-page":"906","volume":"72","author":"ZR Palacios-Baena","year":"2017","unstructured":"Palacios-Baena ZR, Guti\u00e9rrez-Guti\u00e9rrez B, De Cueto M, Viale P, Venditti M, Hern\u00e1ndez-Torres A, et al. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother. 2017;72(3):906\u201313.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1073_CR32","first-page":"906","volume":"72","author":"ZR Palacios-Baena","year":"2017","unstructured":"Palacios-Baena ZR, Gutierrez-Gutierrez B, De Cueto M, Viale P, Venditti M, Hernandez-Torres A, et al. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother. 2017;72(3):906\u201313.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1073_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr. 2019;43(2):181\u201393.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1073_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.","journal-title":"Nutr J"},{"issue":"4","key":"1073_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/CCO.0b013e3283479c66","volume":"23","author":"A Paccagnella","year":"2011","unstructured":"Paccagnella A, Morassutti I, Rosti G. Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol. 2011;23(4):322\u201330.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"1073_CR36","first-page":"274","volume":"27","author":"AVG Fruchtenicht","year":"2015","unstructured":"Fruchtenicht AVG, Poziomyck AK, Kabke GB, Loss SH, Antoniazzi JL, Steemburgo T, et al. Nutritional risk assessment in critically ill cancer patients: systematic review. Rev Bras Ter Intensiva. 2015;27(3):274\u201383.","journal-title":"Rev Bras Ter Intensiva"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01073-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01073-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01073-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T13:19:16Z","timestamp":1644239956000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01073-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01073-3","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"24 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University approved this study (No: XJTU1AF2020LSK-049). Waiving of informed consent was obtained due to the retrospective noninterventional study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}